Table 3. Clinical symptom severity and body regions affected at baseline visit (n = 1,025, discrepancies in totals for different variables are due to missing data).
| Clinical symptom severity | Number of patients |
|---|---|
| IGA | |
| Clear | 15 (1.5%) |
| Almost clear | 61 (6.0%) |
| Mild | 146 (14.4%) |
| Moderate | 400 (39.4%) |
| Severe | 314 (30.9%) |
| Very severe | 79 (7.8%) |
| oSCORAD | |
| oSCORAD, mean (SD) | 40.9 (16.2) (n = 1,016) |
| oSCORAD – Categories | |
| Clear (0 – < 8) | 26 (2.6%) |
| Mild (8 – < 24) | 118 (11.6%) |
| Moderate (24 – < 38) | 295 (29.0%) |
| Severe (38 – 83) | 577 (56.8%) |
| EASI | |
| EASI, mean (SD) | 16.1 (12.9) (n = 1,015) |
| EASI – Categories | |
| Clear (0) | 14 (1.4%) |
| Mild (>0 – <6) | 221 (21.8%) |
| Moderate (6 – <23) | 539 (53.1%) |
| Severe (23 – 72) | 241 (23.7%) |
| Affected body regions | Number of patients |
| n = 1,015 | |
| Face | 792 (78.0%) |
| Hands | 757 (74.6%) |
| Feet | 435 (42.9%) |
| Genital area | 155 (15.3%) |
| Large joint flexions (queried since 2018, n total = 762) | 580 (76.1%) |
| Neck (queried since 2018, n total = 762) | 594 (78.0%) |
SD = standard deviation.